The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
The Biomedical Catalyst has 4 funding strands to support the progression of projects from initial concept through to late stage development:
This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months.
The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system by:
Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.
Be aware that your project may be subject to interim reviews at important decision points.
Any UK business claiming funding must be eligible to receive state aid at the time Innovate UK confirm you will be awarded funding. If you are unsure please take legal advice. For further information see their general guidance.
Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.
If your project’s total eligible costs or duration fall outside of their eligibility criteria, you must provide justification by email to firstname.lastname@example.org at least 10 days before the competition closes. They will decide whether to approve your request.
To lead a project or work alone you must:
You can work alone or in partnership with others (SMEs, academics or research organisations).
If your project is academic-led you need to apply to the Medical Research Council instead.
The lead must claim
To be a collaborator you must:
Projects can include partners that do not receive any funding (for example, non-UK businesses). Their costs will count towards the total eligible project costs but they will not count as collaborators.
Anyone business or RTO can lead on one application and collaborate in a further 2 applications.
If a business is not leading an application, they can be a collaborator in up to 3 applications. If an RTO is:
An academic institution can be a collaborator in any number of applications.
Support is available for any life science sector or discipline, including (but not limited to):
If you choose the innovation area ‘Diagnostics, medical technology and devices’, you must indicate in the initial project summary whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.
We will fund feasibility studies and industrial research projects. Please see the general guidance to help you decide which category your project fits in.
We will not fund projects as part of this competition that: